Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when an Advanced Materials result is sound but its central advance and significance are not yet sharp, or when a Communication's opening paragraph must double as its abstract. Structures the one-advance narrative; does not run characterization or design figures.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
advmat-scope-fit returned Adv. Mater. but flagged the impact framing as weakAn Adv. Mater. paper is organized around one central advance — a new material, a new mechanism, or a new property regime. Everything else is support.
advmat-supplementary).If you have two co-equal advances, you likely have two papers, or one belongs in a sibling journal.
Materials referees reward a clean causal chain. Frame the paper so each link is explicit:
The advance lives at whichever link is genuinely new; name it, and show the chain holds end to end. A paper that jumps from structure to a device metric without the property mechanism in between invites the "why does it work?" rejection.
In a Communication, there is no separate abstract — the first paragraph carries the significance and must read as a self-contained mini-paper. A reliable four-move pattern (also the model for a Research Article abstract):
Do not open with a paragraph-long literature tour. The advance should appear in the first paragraph.
| Symptom | Move |
|---|---|
| Two co-equal headline advances | Split, or demote one to support / SI |
| Result stated as a metric only ("we reached X%") | Reframe as the new material principle that produced it |
| Novelty asserted, not shown | Tie it to the design rule / trade-off it changes |
| Structure→property→function chain has a gap | Add the missing mechanism link, or scope the claim down |
| Opening buried under background | Cut to 2–3 sentences; move detail to the body or SI |
【Primary advance】one sentence
【Title encodes advance】yes / fix
【Structure→property→function】all links present? yes / gap: ...
【Opening moves】context / problem / advance / significance — all present?
【Communication abstract-in-paragraph-1】yes / n/a / fix
【Demoted to SI】list
【Next】advmat-methods (characterization) or advmat-figures (lead figure)
Abstract/keyword/opening rules differ by article type and evolve — verify the current requirements on the official Wiley Advanced Materials author page.
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。